Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen to Re-Brand, Sell Drug Tests Made by American Bio Medica in POC Setting

NEW YORK (GenomeWeb News) – Nanogen today said it will market point-of-care tests for drugs of abuse made by American Bio Medica into the "hospital-related" setting.
 
Nanogen will re-brand the tests under its Tox STATus name and sell them using its existing sales force and distribution network. American Bio Medica will continue to sell the tests under their original brand to its core criminal justice and workplace markets, a spokesperson for the company said.
 
The tests, which are cleared by US and European regulators, can detect up to 15 commonly abused substances including cocaine, methamphetamine, and marijuana.
 
Nanogen said it expects to begin distributing the tests before the end of the year.
 
Financial terms of the deal were not disclosed.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.